en

PRODUCT DETAIL

HALAVEN 0,44 mg/ml injekčný roztok

Code 07826
MA number EU/1/11/678/002
Product Form: sol inj 6x2 ml/0,88 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX41 Eribulin
Shelf life: 60
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 17.03.2011
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 05.04.2022
eu-flag.png sk-flag.png